Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies - PubMed (original) (raw)
. 1982 Mar;128(3):1221-8.
- PMID: 6173426
Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies
M K Ho et al. J Immunol. 1982 Mar.
Abstract
Two monoclonal antibodies, M3/31 and M3/38, were obtained by fusion of mouse myeloma cells with rat spleen cells immunized to immunoadsorbent-purified macrophage glycoproteins. Co-precipitation experiments show that antigenic determinants recognized by these two antibodies reside on the same molecular species, termed Mac-2, Mac-2, an antigen of 32,000 Mr, is synthesized by and expressed on the surface of thioglycollate-elicited macrophages as shown by [35S]-methionine and 125I labeling. Saturation binding experiments show that thioglycollate-elicited macrophages express 1.7 X 10(5) Mac-2 sites/cell. Thioglycollate-elicited macrophages are strongly absorptive for 125I-labeled M3/38 MAb. Kidneys are also absorptive; however, evidence is presented pointing to the nonspecificity of this absorption. Lymph node and thymus are negative, whereas spleen and bone marrow are weakly absorptive, probably due to stromal cells. Nonlymphoid tissues, such as lung, liver, heart, and brain, exhibit slight or no absorbing capacity. Cell suspensions from spleen, bone marrow, thymus, and peripheral lymph node are greater than 99% Mac-2- by immunofluorescent flow cytometry. In contrast, thioglycollate-elicited macrophages are greater than 96% strongly positive for Mac-2. Only 20% of peptone-elicited cells are weakly positive, whereas resident peritoneal macrophages and other macrophage elicited by Listeria monocytogenes, Con A, or LPS are greater than 98% negative. SDS-PAGE of [35S]-methionine-labeled Mac-2 shows that thioglycollate-elicited macrophages synthesize 10- to 30-fold more Mac-2 than other peritoneal macrophage subpopulations, whereas all types of peritoneal macrophages synthesize and express on their surfaces similar amounts of the Mac-1 antigen. Mac-2 antigen is therefore induced in macrophages only in response to specific differentiative signals.
Similar articles
- Effects of immobilized immune complexes on Fc- and complement-receptor function in resident and thioglycollate-elicited mouse peritoneal macrophages.
Michl J, Pieczonka MM, Unkeless JC, Silverstein SC. Michl J, et al. J Exp Med. 1979 Sep 19;150(3):607-21. doi: 10.1084/jem.150.3.607. J Exp Med. 1979. PMID: 383878 Free PMC article. Review. - Markers of mouse macrophage development detected by monoclonal antibodies.
Leenen PJ, de Bruijn MF, Voerman JS, Campbell PA, van Ewijk W. Leenen PJ, et al. J Immunol Methods. 1994 Sep 14;174(1-2):5-19. doi: 10.1016/0022-1759(94)90005-1. J Immunol Methods. 1994. PMID: 8083537 Review.
Cited by
- The Role of Galectins in Asthma Pathophysiology: A Comprehensive Review.
Portacci A, Iorillo I, Maselli L, Amendolara M, Quaranta VN, Dragonieri S, Carpagnano GE. Portacci A, et al. Curr Issues Mol Biol. 2024 May 3;46(5):4271-4285. doi: 10.3390/cimb46050260. Curr Issues Mol Biol. 2024. PMID: 38785528 Free PMC article. Review. - Platelet-derived growth factor receptor beta is required for embryonic specification and confinement of the adult white adipose lineage.
Benvie AM, Lee D, Jiang Y, Berry DC. Benvie AM, et al. iScience. 2023 Dec 12;27(1):108682. doi: 10.1016/j.isci.2023.108682. eCollection 2024 Jan 19. iScience. 2023. PMID: 38235323 Free PMC article. - Antibody-mediated neutralization of galectin-3 as a strategy for the treatment of systemic sclerosis.
Ortega-Ferreira C, Soret P, Robin G, Speca S, Hubert S, Le Gall M, Desvaux E, Jendoubi M, Saint-Paul J, Chadli L, Chomel A, Berger S, Nony E, Neau B, Fould B, Licznar A, Levasseur F, Guerrier T, Elouej S, Courtade-Gaïani S, Provost N, Nguyen TQ, Verdier J, Launay D, De Ceuninck F. Ortega-Ferreira C, et al. Nat Commun. 2023 Aug 31;14(1):5291. doi: 10.1038/s41467-023-41117-9. Nat Commun. 2023. PMID: 37652913 Free PMC article. - The pleiotropic role of galectin-3 in melanoma progression: Unraveling the enigma.
Mohammed NBB, Antonopoulos A, Dell A, Haslam SM, Dimitroff CJ. Mohammed NBB, et al. Adv Cancer Res. 2023;157:157-193. doi: 10.1016/bs.acr.2022.06.001. Epub 2022 Aug 8. Adv Cancer Res. 2023. PMID: 36725108 Free PMC article. Review. - Decoding Strategies to Evade Immunoregulators Galectin-1, -3, and -9 and Their Ligands as Novel Therapeutics in Cancer Immunotherapy.
Lau LS, Mohammed NBB, Dimitroff CJ. Lau LS, et al. Int J Mol Sci. 2022 Dec 8;23(24):15554. doi: 10.3390/ijms232415554. Int J Mol Sci. 2022. PMID: 36555198 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Research Materials
Miscellaneous